Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/30/2026

1. META
2. MSFT
3. V
4. SPY
5. PYPL
6. KLAC
7. BE
8. SWKS
9. F
10. STX

Go back to Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026
(NASDAQ: ASMB) Delayed: 25.11 -0.46 (1.8%)
Previous Close $25.57    52 Week High $14.50 
Open $25.75    52 Week Low $4.33 
Day High $25.87    P/E N/A 
Day Low $24.50    EPS $0.00 
Volume 153,276